162 filings
Page 2 of 9
8-K
seyjb
9 May 23
Verrica Pharmaceuticals Reports First Quarter 2023 Financial Results
8:13am
DEFA14A
7vjhm8mge tqai3
21 Apr 23
Additional proxy soliciting materials
8:55am
ARS
8oy8hmza5zo
21 Apr 23
Annual report to shareholders
8:45am
8-K
7vildk3s7siox8 h4qy
6 Mar 23
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results
7:46am
424B5
nvirgtnvsgwsc
22 Feb 23
Prospectus supplement for primary offering
4:17pm
8-K
x2x030ny9dr
21 Feb 23
Verrica Announces Pricing of $32.5 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
8:58am
FWP
rvnrod h3f1d2e122dmb
21 Feb 23
Free writing prospectus
6:19am
8-K
7uqa92uvnb
21 Feb 23
Results of Operations and Financial Condition
6:08am
8-K
hqd1o
2 Feb 23
Regulation FD Disclosure
4:16pm
8-K
qnnrsqgu
24 Jan 23
Other Events
7:58am
EFFECT
2t28n3axl8tc8
20 Dec 22
Notice of effectiveness
12:15am
424B5
ykc2g463lm6
19 Dec 22
Prospectus supplement for primary offering
4:16pm
CORRESP
x42hnciw6aslw 5n
15 Dec 22
Correspondence with SEC
12:00am
UPLOAD
u7ev1psyvzbrz3e
29 Nov 22
Letter from SEC
12:00am
CORRESP
y3xkqhhloc53db
18 Nov 22
Correspondence with SEC
12:00am
UPLOAD
hjxv4
15 Nov 22
Letter from SEC
12:00am
UPLOAD
wbzvxu xqwmoqppv2wt4
8 Nov 22
Letter from SEC
12:00am